Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 01/15/2021

Closing price: 275.84

Support price level:	$274.84
Resistance price level:	N/A
Relative strength index (14-day RSI)	75.8
Beta	0.61

Up 9.2 percent, BIIB is one of this week's biggest gainers.
Volatility is forecast to fall over the next month.
With RSI > 70, BIIB is overbought. Odds slightly favor a short-term price reversal.
Price broke above prior resistance level - a short-term bullish signal.

Low	High	Price as % of Range
$236.26	$355.63	37.9%

200 day	50 day	20 day	10 day
$278.37	$253.44	$253.50	$259.78

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
44.2%	35.3%	40.8%	44.7%

There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than: